Global Leadership, Powered by Integrated Talent Technology.
The Gold Standard for Global Placements.
Livasyst specializes in identifying and placing high-profile professionals for senior leadership roles where technical depth is non-negotiable. Our research-driven methodology targets "Passive Talent"-high-performing leaders currently excelling in their roles who are not visible through traditional recruitment channels.
We conduct in-depth industry mapping to identify candidates across sub-sectors (e.g., Cell & Gene Therapy, Rare Diseases, Digital Health).
Each candidate undergoes a structured behavioral assessment to ensure alignment with your organization's mission and long-term vision.
We prioritize confidentiality, acting as your brand ambassadors in the most sensitive talent markets.
Integrating Acquisition with Organizational Architecture.
We act as an extension of your team, merging elite Talent Acquisition with Strategic Consulting. We don’t just fill vacancies; we analyze your organizational architecture to ensure every senior hire aligns with your clinical pipeline and commercial milestones.
We design phased hiring plans that match your funding cycles (Seed to Series C) and development stages (IND to BLA).
Defining the specific competencies required for success at each inflection point of your company’s growth.
Partnering with Private Equity and VC firms to build resilient leadership teams within their biopharmaceutical portfolios.
Building Global Hubs through ‘Vector’ Technology.
Livasyst empowers organizations to establish Global Capability Centers (GCC) that function as strategic innovation engines. We provide the digital-first infrastructure needed to scale global teams while maintaining total regulatory and operational integrity.
We are currently engineering our proprietary Vector HRMS, a next-generation platform tailored specifically for the regulatory rigors of the Life Sciences industry.
Vector is being built to unify payroll, statutory compliance and talent management into a single, secure environment.
In the coming phase, Vector will allow your global hubs to co-own clinical outcomes with real-time transparency for C-suite leaders.
Let’s discuss your pipeline’s leadership needs and how we can identify the talent that will turn your scientific potential into market reality.
Get in Touch Today